PTPI (Petros Pharmaceuticals) Accounts Payable: $0.13 Mil (As of Mar. 2026)


What is Petros Pharmaceuticals Accounts Payable?

Petros Pharmaceuticals PTPI -2.15% Accounts Payable is $0.13 Mil as of Mar. 2026.

Petros Pharmaceuticals's Accounts Payable for the quarter that ended in Mar. 2026 was $0.13 Mil.

Petros Pharmaceuticals's quarterly Accounts Payable declined from Sep. 2025 ($0.42 Mil) to Dec. 2025 ($0.08 Mil) but then increased from Dec. 2025 ($0.08 Mil) to Mar. 2026 ($0.13 Mil).

Petros Pharmaceuticals's annual Accounts Payable declined from Dec. 2023 ($1.71 Mil) to Dec. 2024 ($0.76 Mil) and declined from Dec. 2024 ($0.76 Mil) to Dec. 2025 ($0.08 Mil).


Petros Pharmaceuticals Accounts Payable Related Terms


Petros Pharmaceuticals Accounts Payable Historical Data

* Premium members only.

The historical data trend for Petros Pharmaceuticals's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Petros Pharmaceuticals Accounts Payable Chart

Petros Pharmaceuticals Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Accounts Payable
Get a 7-Day Free Trial 4.56 1.81 1.71 0.76 0.08

Petros Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.46 0.97 0.42 0.08 0.13

Petros Pharmaceuticals Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.13 Mil mean?
Petros Pharmaceuticals (PTPI) has a Accounts Payable of $0.13 Mil as of Mar. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Petros Pharmaceuticals and its competitors.
Is Petros Pharmaceuticals' Accounts Payable too high?
Petros Pharmaceuticals' current Accounts Payable is $0.13 Mil.
How does Petros Pharmaceuticals' Accounts Payable compare to STEK and KOAN?
Petros Pharmaceuticals' Accounts Payable of $0.13 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Drug Manufacturers company?
A good Accounts Payable depends on the Drug Manufacturers industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Petros Pharmaceuticals and its competitors. Petros Pharmaceuticals's current Accounts Payable is $0.13 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Petros Pharmaceuticals stock overvalued right now?
Petros Pharmaceuticals (PTPI) has a current Accounts Payable of $0.13 Mil. The current Accounts Payable is $0.13 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Petros Pharmaceuticals (PTPI), the current Accounts Payable is $0.13 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Petros Pharmaceuticals Business Description

Address 1185 Avenue of the Americas, 3rd Floor, New York, NY, USA, 10036
Petros Pharmaceuticals Inc is a men's health pharmaceutical company. The Company is working towards the goal of becoming an innovator in the emerging self-care market, driving expanded access to key nonprescription pharmaceuticals as Over-the-Counter and nonprescription drug products with additional conditions for nonprescription use (ACNU Products) treatment options. Petros is pursuing the development of a proprietary integrated technology solutions platform containing two components: SaaS, designed to assist pharmaceutical companies in operationalizing and commercializing an Rx-to-OTC switch as an element in the development of an ACNU Product, and a potential Software as a Medical Device component, which guides the consumer in navigating appropriate self-selection or deselection.